Conclusion of a non-exclusive rebate agreement pursuant to Section 130a(8) of the German Social Code Book V for the active substance ganirelix, ATC H01CC01, for the period 01/06/2026 to 31/05/2028 (plus option to extend once by 12 months)

Summary

The tender concerns a non-exclusive rebate agreement for medicines containing the active substance ganirelix for the period 01/06/2026 to 31/05/2028, with an option to extend once by 12 months. It is an open accession model: interested pharmaceutical companies may join the contract if they submit the required documents by email on time. No tender guarantee is required. The exact qualification and exclusion requirements must be checked in the tender documents.